Interestingly, the activation of Akt in response to CSF1 in Trem2-deficient microglia indicates that CSF1 may be a potential therapeutic molecule for TREM2-loss-of-function neurodegenerative disease. The gene discussed is TREM2; the disease is neurodegenerative disease.